ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 759018 Null 0.049093561024907 0.18356532
NSC 759878 Irinotecan hydrochloride (USAN) 0.049093561024907 0.71532087
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.049093561024907 0.28652292
NSC 99445 1-.beta.-D-Arabinofuranosylcytosine 5'-phosphate 0.049093561024907 0.70381911
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 1.49667137663235e-005 0.69951922
NSC 726769 5,6-Dihydro-6-(4-amino-1-butyl)-5,11-dioxo-11H-indeno{1,2-c] isoquinoline Hydrochloride 1.67337200997165e-006 0.79880364
NSC 15628 Cinnasil 2.60114781708976e-005 0.37235054
NSC 618939 Camptothecin Derivative 3.40252996142934e-005 0.77439086
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 3.40252996142934e-005 0.70519045
NSC 725774 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 3.40252996142934e-005 0.6239009
Total:122  Current:121    [First] [Prev] [Next] [Last]